Try our Advanced Search for more refined results
Health
- 
									September 25, 2025
									Oracle, Meta Mull $20B AI Deal, As Tech Rumors AboundOracle Corp. is said to be in discussions with Meta on a multiyear cloud computing deal worth a potential $20 billion, Reuters reported on Sept. 19. The report came just days before a bombshell announcement from Nvidia about its $100 billion staged investment in OpenAI. 
- 
									September 25, 2025
									Labcorp Workers Balk At Paying For Expert's Biz Class AirfareLabcorp shouldn't be reimbursed for its expert witness's round-trip business class flight and other ancillary costs it wants a group of employees to pay after fending off claims that it mismanaged their retirement savings, the workers have told a North Carolina federal judge. 
- 
									September 25, 2025
									Depo-Provera MDL Plaintiff Numbers Balloon To 1,300The plaintiffs in a multidistrict litigation claiming Pfizer failed to warn consumers of a link between brain tumors and the hormonal contraceptive Depo-Provera now number more than 1,300, with more expected to file suits ahead of a hearing Monday on whether their claims are preempted by federal law. 
- 
									September 25, 2025
									Aetna Can't Rein In LGBTQ+ Bias Suit Over Fertility CoverageAetna can't narrow a proposed class action alleging it unlawfully required nonheterosexual patients to spend thousands of dollars before covering fertility treatments, as a Connecticut federal judge said the insurer failed to fully acknowledge its role in creating the health plan in question. 
- 
									September 25, 2025
									Families Cite Trump In Bid To Revive Tylenol Autism ClaimsFamilies suing the maker of Tylenol quickly cited President Donald Trump's words this week as they pushed the Second Circuit to overturn a lower-court ruling that barred their expert witnesses from testifying that prenatal exposure to the medicine can cause autism. 
- 
									September 25, 2025
									Conn. Cities' Insulin Pricing Suits Against PBMs Join NJ MDLTwo Connecticut cities' civil racketeering and state trade practices law claims against insulin manufacturers Eli Lilly and Co., Novo Nordisk Inc. and Sanofi-Aventis US LLC, and pharmacy benefit managers CVS Caremark, Express Scripts and Optum Rx, have been rolled into a New Jersey multidistrict litigation proceeding. 
- 
									September 25, 2025
									Second 'Drugs Made In America' SPAC Raises $500M In IPODrugs Made In America Acquisition II, a special purpose acquisition company planning to target companies in the pharmaceutical industry, began trading publicly on Thursday after pricing a $500 million initial public offering, marking the largest SPAC listing of 2025. 
- 
									September 24, 2025
									DC Judge Won't Reinstate IGs Over 'Obvious' Trump ViolationA Washington, D.C., federal judge on Wednesday declined to reinstate eight inspectors general whom President Donald Trump fired without warning or rationale, finding that while it is "obvious" the president violated federal law governing the removal of inspectors general, the plaintiffs have not shown irreparable harm. 
- 
									September 24, 2025
									Ga. Panel Reverses Early Win In Ambulance-Mower CrashA Georgia appellate panel revived a negligence claim Wednesday from a man who said he was hit by a speeding ambulance while crossing a road in his lawn mower, rejecting a trial court's finding that there was "no evidence" the ambulance driver was at fault. 
- 
									September 24, 2025
									UnitedHealth Fights Investor Suit Over DOJ's Merger ProbeUnitedHealth and its executives have asked a Minnesota federal judge to toss a proposed securities class action accusing it of, among many things, not disclosing that the U.S. Department of Justice had reopened an antitrust investigation into the health insurer, saying the complaint consists of unsupported "scattershot allegations." 
- 
									September 24, 2025
									Google, Flo To Pay Combined $56M To End Data Privacy SuitGoogle LLC will shell out $48 million and app developer Flo Health Inc. will pay $8 million to resolve a class action over the popular menstrual tracking app's allegedly unlawful sharing of sensitive health data with Google and others through online tracking tools, according to documents filed by the app's users in California federal court. 
- 
									September 24, 2025
									Pharmacies Labeled As Gatekeepers In Fla. Opioid TrialA medical doctor who testified Wednesday in a Florida state court trial against Walgreens, Walmart and CVS over their alleged conspiracy to push addictive painkiller drugs characterized their pharmacists as gatekeepers in dispensing the medications, saying they had the ability to break the pharmaceutical companies' ability to make money off the opioid epidemic. 
- 
									September 24, 2025
									Planned Parenthood Shooter Still Not Competent For TrialThe man accused of killing three people and injuring several more at a Colorado Springs Planned Parenthood in 2015 may never stand trial after a Colorado federal judge on Wednesday granted a joint motion to find the man incompetent to proceed despite his receiving rehabilitation services. 
- 
									September 24, 2025
									CVS Moves To End Worker's Tobacco Surcharge ERISA SuitCVS urged a California federal judge to toss an employee's proposed class action alleging it illegally imposes surcharges to health plan participants and their covered spouses who use tobacco, arguing it offers surcharge alternatives to workers and spouses when a medical condition makes it unreasonably difficult to cease tobacco use. 
- 
									September 24, 2025
									Court Sides With Texas, Nixes Medicaid Tax Funding RuleThe federal government improperly expanded a Medicaid funding restriction to private parties that was meant only to govern the use of state taxes to fund the health insurance program, a Texas federal court ruled Wednesday in vacating guidance from the Centers for Medicare & Medicaid Services. 
- 
									September 24, 2025
									Omnicare Can Tap $25M Initial DIP, Stage Set For Gov't FeudOmnicare LLC, a CVS Health subsidiary that provides pharmacy services for long-term care facilities, won a Texas bankruptcy court approval on Wednesday to use $25 million of interim debtor-in-possession financing amid a looming dispute over a $949 million judgment owed to the U.S. government over allegedly illegal billing. 
- 
									September 24, 2025
									Minn. Justices Reject Humana's Pharmacy Sourcing AppealThe Minnesota Supreme Court rejected arguments by a Humana subsidiary that its sales of pharmacy benefit services attributed to Minnesota should instead be sourced to a Humana unit in Wisconsin, denying the company a $834,000 refund Wednesday. 
- 
									September 24, 2025
									Committee Says $100M DIP Loan Doesn't Benefit ModivcareThe official committee of unsecured creditors in the Chapter 11 case of medical transport company Modivcare objected to final approval of the debtor's $100 million bankruptcy loan late Tuesday, telling a Texas court the package includes "numerous infirmities" that need to be addressed. 
- 
									September 24, 2025
									NC Med. Provider Exposed 450K Peoples' Data, Patient SaysA healthcare provider with locations throughout eastern North Carolina failed to protect the private data of at least 450,000 of its patients, then dragged its feet in notifying them, according to a potential class action filed in North Carolina federal court Tuesday. 
- 
									September 24, 2025
									Trans Youth Care Ban Discriminatory, Mo. High Court HearsThe Missouri Supreme Court heard arguments Wednesday on a law that bans gender-affirming care for minors and restricts Medicaid coverage for transgender care at any age, but the justices gave little indication of how they might rule. 
- 
									September 24, 2025
									Medical Marijuana Operators Claim Okla. Undermines IndustryA group of Oklahoma medical marijuana interests allege in a new federal lawsuit that state officials are unlawfully hindering their operations as part of a broad crackdown on the industry. 
- 
									September 24, 2025
									4th Circ. Kicks Trans Care Exclusion Suits Back To Trial CourtA pair of suits challenging health plan coverage exclusions on gender-affirming care for minors are headed to district court after the Fourth Circuit vacated decisions finding those policies discriminatory, in line with a U.S. Supreme Court directive to revisit the cases in light of new precedent. 
- 
									September 24, 2025
									DOJ Likely Crossed Line With Mangione Remarks, Judge SaysTop officials at the U.S. Department of Justice are in hot water for linking alleged insurance CEO killer Luigi Mangione to left-wing terrorism and potentially violating his right to a fair trial, a New York federal judge said Wednesday as she threatened sanctions for future violations. 
- 
									September 24, 2025
									Helicopter Cos. Say Aetna 'Grasping At Straws' In $20M FightThree Aetna entities have "trumped up" their counterclaims against six air ambulance operators that are suing insurers for $20 million in Connecticut federal court, according to a dismissal motion that says the allegations of dirty dealing are preempted. 
- 
									September 24, 2025
									Let States Use Leftover BEAD Funds, Sen. Wicker SaysStates should be able to use money left over from federal grants aimed at broadband deployment for other projects to boost high-tech growth, a Republican senator said. 
Expert Analysis
- 
								Series Playing Poker Makes Me A Better Lawyer  Poker is a master class in psychology, risk management and strategic thinking, and I’m a better attorney because it has taught me to read my opponents, adapt when I’m dealt the unexpected and stay patient until I'm ready to reveal my hand, says Casey Kingsley at McCreadyLaw. 
- 
								
								What EU 'Killer Acquisition' Study Means For Pharma Deals  The European Commission’s recent study of pharmaceutical companies' acquisitions of emerging competitive threats, the first of its kind globally, has important implications for the industry, and may lead to increased awareness of merger control risks in collaborative agreements, say lawyers at Paul Weiss. 
- 
								
								Legal Risks For Providers Discussing Psychedelic Therapies  The emergence of psychedelic therapies as potential treatments for mental health conditions and other ailments continues to garner significant attention, but the legal landscape surrounding discussions and referrals remains fraught with complexity, creating potential risks for healthcare providers and institutions, says Kimberly Chew at Husch Blackwell. 
- 
								
								Why Texas Should Slow Down On Healthcare Merger Bills  More time is needed to study three Texas bills aimed at considering the effects of healthcare consolidation to increase affordability and access to healthcare, which could have the opposite effect, say John Saran and Harshita Rathore at Holland & Knight and Robbie Allen at U.S. Heart and Vascular. 
- 
								Series Law School's Missed Lessons: Becoming A Firmwide MVP  Though lawyers don't have a neat metric like baseball players for measuring the value they contribute to their organizations, the sooner new attorneys learn skills frequently skipped in law school — like networking, marketing, client development and case evaluation — the more valuable, and less replaceable, they will be, says Alex Barnett at DiCello Levitt. 
- 
								
								How NY's FAIR Act Mirrors sa¹ú¼Ê´«Ã½ State Recommendations  New York's proposed FAIR Business Practices Act, which targets predatory lending and junk fees, reflects the Rohit Chopra-era Consumer Financial Protection Bureau's recommendations to states in a number of ways, including by defining "abusive" conduct and adding a new right to file class actions, says Christian Hancock at Bradley Arant. 
- 
								
								A Breakdown Of Trump's Order On Drug Pricing  The Trump administration may attempt to effectuate through rulemaking a recently issued executive order on lowering drug prices, which would likely have an adverse effect on stakeholders and trigger litigation, say attorneys at Debevoise. 
- 
								
								Takeaways From DOJ's 1st Wage-Fixing Jury Conviction  U.S. v. Lopez marked the U.S. Department of Justice's first labor market conviction at trial as a Nevada federal jury found a home healthcare staffing executive guilty of wage-fixing and wire fraud, signaling that improper agreements risk facing successful criminal prosecution, say attorneys at McGuireWoods. 
- 
								
								Bid Protest Spotlight: Size, Supply Schedules, SINs  In this month's bid protest roundup, Alissandra McCann at MoFo examines three recent decisions, two of which offer helpful reminders for U.S. General Services Administration schedule holders drafting blanket purchase agreement proposals, and one for small-business joint ventures to avoid running afoul of the U.S. Small Business Administration's two-year rule. 
- 
								
								Del. Bill Reflects Nat'l Tug-Of-War Between Cannabis, Alcohol  As Delaware's bill targeting hemp-derived THC beverages and ingestible products moves through the general assembly, it reads like a local regulatory fix — but in reality, it's a microcosm of a national power struggle playing out state-by-state across the cannabis frontier, says attorney Peter Murphy. 
- 
								
								$38M Law Firm Settlement Highlights 'Unworthy Client' Perils  A recent settlement of claims against law firm Eckert Seamans for allegedly abetting a Ponzi scheme underscores the continuing threat of clients who seek to exploit their lawyers in perpetrating fraud, and the critical importance of preemptive measures to avoid these clients, say attorneys at Lockton Companies. 
- 
								
								Only Certainty About FAR Reform Order Is Its Uncertainty.jpg)  The president’s recent order overhauling the Federal Acquisition Regulation, which both contractors and agencies rely on to ensure predictability and consistency in federal procurement, lacks key details about its implementation, which will likely eliminate many safeguards that ensure contractors are treated fairly and that procurements are awarded in a reasonable manner, say attorneys at Miles & Stockbridge. 
- 
								
								Maintaining Legal Compliance For GenAI In Life Sciences  As companies continue to implement generative artificial intelligence to enhance all phases of drug discovery, they must remain mindful of legal, regulatory and practical considerations as best practices in this space emerge and evolve, say attorneys at Sullivan & Cromwell. 
- 
								Series Teaching Business Law Makes Me A Better Lawyer.jpg)  Teaching business law to college students has rekindled my sense of purpose as a lawyer — I am more mindful of the importance of the rule of law and the benefits of our common law system, which helps me maintain a clearer perspective on work, says David Feldman at Feldman Legal Advisors. 
- 
								
								Gauging Professional Sport Biometric Data Privacy Concerns  In today's data-driven sports industry, teams, leagues and sponsors increasingly rely on biometric and performance data to enhance player performance, prevent injuries and optimize contract negotiations, but this growing reliance on highly sensitive data raises significant legal and privacy concerns, particularly in light of evolving biometric privacy laws, say attorneys at Foley & Lardner. 
